A detailed history of American Portfolios Advisors transactions in Catalent, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,035 shares of CTLT stock, worth $63,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,035
Holding current value
$63,135
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$72.36 - $113.1 $74,892 - $117,058
1,035 New
1,035 $74.9 Million
Q2 2022

Mar 20, 2023

SELL
$87.2 - $114.05 $4,883 - $6,386
-56 Reduced 5.41%
979 $105 Million
Q1 2022

Mar 21, 2023

SELL
$94.19 - $124.49 $14,976 - $19,793
-159 Reduced 15.36%
876 $97.1 Million
Q4 2021

Mar 21, 2023

SELL
$119.57 - $139.07 $35,034 - $40,747
-293 Reduced 28.31%
742 $95 Million
Q3 2021

Mar 22, 2023

SELL
$109.17 - $142.35 $36,026 - $46,975
-330 Reduced 31.88%
705 $93.8 Million
Q2 2021

Mar 22, 2023

SELL
$100.34 - $115.69 $55,488 - $63,976
-553 Reduced 53.43%
482 $52.1 Million
Q1 2021

Mar 22, 2023

SELL
$101.51 - $125.27 $67,301 - $83,054
-663 Reduced 64.06%
372 $39.2 Million
Q4 2020

Mar 22, 2023

SELL
$85.88 - $105.36 $73,169 - $89,766
-852 Reduced 82.32%
183 $19 Million
Q3 2020

Mar 22, 2023

SELL
$72.74 - $92.5 $62,992 - $80,105
-866 Reduced 83.67%
169 $14.5 Million
Q2 2020

Mar 24, 2023

SELL
$48.02 - $79.04 $192 - $316
-4 Reduced 2.2%
178 $13 Million
Q1 2020

Mar 24, 2023

SELL
$36.95 - $62.95 $31,518 - $53,696
-853 Reduced 82.42%
182 $9.46 Million
Q4 2019

Mar 24, 2023

SELL
$47.06 - $56.64 $41,036 - $49,390
-872 Reduced 84.25%
163 $9.18 Million
Q3 2019

Mar 24, 2023

SELL
$47.45 - $58.05 $2,325 - $2,844
-49 Reduced 35.0%
91 $4.34 Million
Q2 2019

Mar 24, 2023

SELL
$39.26 - $54.21 $35,137 - $48,517
-895 Reduced 86.47%
140 $7.59 Million
Q1 2019

Mar 24, 2023

BUY
$29.84 - $43.92 $3,163 - $4,655
106 New
106 $4.3 Million
Q4 2018

Mar 24, 2023

SELL
$29.95 - $46.34 $2,755 - $4,263
-92 Closed
0 $0
Q3 2018

Mar 24, 2023

SELL
$40.12 - $45.55 $37,833 - $42,953
-943 Reduced 91.11%
92 $4.19 Million
Q1 2018

Mar 24, 2023

SELL
$39.4 - $47.39 $37,981 - $45,683
-964 Reduced 93.14%
71 $2.92 Million
Q4 2017

Mar 24, 2023

SELL
$37.27 - $43.02 $35,928 - $41,471
-964
71 $2.92 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.